Harmony Biosciences(HRMY) - 2024 Q4 - Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2024 Earnings Conference Call February 25, 2025 8:30 AM ET Company Participants Jeffrey Dayno - President, Chief Executive Officer Jeffrey Dierks - Chief Commercial Officer Kumar Budur - Chief Medical Officer, Scientific Officer Sandip Kapadia - Chief Financial Officer, Chief Administrative Officer Brennan Doyle - Head of Investor Relations Conference Call Participants Charles Duncan - Cantor Fitzgerald John Gregory Dean - Oppenheimer David Amsellem - Pipe ...